AMYLOID CARDIOMYOPATHY

Clinical trials for AMYLOID CARDIOMYOPATHY explained in plain language.

Never miss a new study

Get alerted when new AMYLOID CARDIOMYOPATHY trials appear

Sign up with your email to follow new studies for AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3

Can a daily pill keep a rare heart disease in check for the long haul?

Disease control Not yet recruiting

This study tests the long-term safety and tolerability of acoramidis, an oral medication that stabilizes the transthyretin protein, in people newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition that can lead to heart failure. Participants who complete…

Matched conditions: AMYLOID CARDIOMYOPATHY

Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

AMYLOID CARDIOMYOPATHY

Get alerted when new AMYLOID CARDIOMYOPATHY trials appear

Can a daily pill keep a rare heart disease in check for the long haul?